Works matching IS 14363291 AND DT 2011 AND VI 14 AND IP 1
Results: 13
Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 50, doi. 10.1007/s10120-011-0007-7
- By:
- Publication type:
- Article
Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 4, doi. 10.1007/s10120-011-0005-9
- By:
- Publication type:
- Article
Trans-vaginal specimen extraction following totally laparoscopic subtotal gastrectomy in early gastric cancer.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 91, doi. 10.1007/s10120-011-0006-8
- By:
- Publication type:
- Article
Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 41, doi. 10.1007/s10120-011-0004-x
- By:
- Publication type:
- Article
Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 56, doi. 10.1007/s10120-011-0008-6
- By:
- Publication type:
- Article
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 28, doi. 10.1007/s10120-011-0003-y
- By:
- Publication type:
- Article
Adjuvant chemoradiation for resected gastric cancer: a 10-year experience.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 63, doi. 10.1007/s10120-011-0011-y
- By:
- Publication type:
- Article
Depth-predicting score for differentiated early gastric cancer.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 35, doi. 10.1007/s10120-011-0002-z
- By:
- Publication type:
- Article
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 81, doi. 10.1007/s10120-011-0016-6
- By:
- Publication type:
- Article
Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 22, doi. 10.1007/s10120-011-0001-0
- By:
- Publication type:
- Article
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 13, doi. 10.1007/s10120-011-0017-5
- By:
- Publication type:
- Article
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 72, doi. 10.1007/s10120-011-0009-5
- By:
- Publication type:
- Article
Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment.
- Published in:
- 2011
- By:
- Publication type:
- Editorial